Peginterferon Alfa-2b in Treating Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery
Condition: Childhood CraniopharyngiomaInterventions: Biological: peginterferon alfa-2b; Other: laboratory biomarker analysisSponsors: Pediatric Brain Tumor Consortium; National Cancer Institute (NCI)Recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2013 Category: Research Source Type: clinical trials
Peginterferon Alfa-2b in Treating Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery
Condition: Childhood CraniopharyngiomaInterventions: Biological: peginterferon alfa-2b; Other: laboratory biomarker analysisSponsors: Pediatric Brain Tumor Consortium; National Cancer Institute (NCI)Not yet recruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 14, 2013 Category: Research Source Type: clinical trials
Peginterferon Alfa-2b in Treating Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery
Condition: Childhood CraniopharyngiomaInterventions: Biological: peginterferon alfa-2b; Other: laboratory biomarker analysisSponsors: Pediatric Brain Tumor Consortium; Pediatric Brain Tumor Consortium; National Cancer Institute (NCI)Not yet recruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 14, 2013 Category: Research Source Type: clinical trials
Peginterferon Alfa-2b in Treating Younger Patients With Craniopharyngioma That is Recurrent or Cannot Be Removed By Surgery
Condition: Childhood CraniopharyngiomaInterventions: Biological: peginterferon alfa-2b; Other: laboratory biomarker analysisSponsors: Pediatric Brain Tumor Consortium; National Cancer Institute (NCI)Not yet recruiting - verified October 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 14, 2013 Category: Research Source Type: clinical trials
